The FDA granted accelerated approval to dostarlimab (Jemperli) on October 19, 2026, for adults with stage II/III locally ...

Arkansas beat Vanderbilt 31-21 to snap its SEC losing streak. The good, bad and ugly reveal what worked and what still needs ...

Eli Lilly and Company announced that new data from across its oncology portfolio will be presented at the European Society for Medical Oncology Congress, taking place October 23?27 in Madrid, Spain.

Everyone is seeing "You Can See Everything," the Elizabeth Holmes documentary that just snagged a record opening weekend at the box office.

Johnson & Johnson (NYSE: JNJ) today announced one-year results from the Phase 3 FUZION study showing TREMFYA® (guselkumab) ...

Three changes show what AI is already doing to everyday care. For someone with diabetes, an automated insulin delivery system ...

President Donald Trump is intensifying his campaign push for Republican candidates as Democrats target the president and ...

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II clinical data on its Nectin-4-targeting antibody-drug conjug ...

Army general warns next war could hit U.S. homeland before troops even deploy; Trump considers using ‘mother of all bombs’ ...

We break down the first FDA-approved myopia treatment glasses, candidate eligibility for kids, and daily wear expectations.